Skip to main content
JAMA Network logoLink to JAMA Network
. 2022 Apr 27;158(6):706. doi: 10.1001/jamadermatol.2022.1379

Errors in Table 1

PMCID: PMC9047722  PMID: 35475874

In the Original Investigation titled “Assessing the Potential for Patient-led Surveillance After Treatment of Localized Melanoma (MEL-SELF): A Pilot Randomized Clinical Trial,”1 published online on November 24, 2021, in JAMA Dermatology, there were 2 minor errors in Table 1. The number of participants with 1 melanoma was adjusted from a total of 77 to 76, and for 3 melanomas, from 10 to 11. The respective percentages were adjusted as well. These changes did not affect the results of the data analysis. This article was corrected online.

Reference

  • 1.Ackermann DM, Dieng M, Medcalf E, et al. Assessing the potential for patient-led surveillance after treatment of localized melanoma (MEL-SELF): a pilot randomized clinical trial. JAMA Dermatol. 2022;158(1):33-42. doi: 10.1001/jamadermatol.2021.4704 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from JAMA Dermatology are provided here courtesy of American Medical Association

RESOURCES